Stock Events

Stock Events

PRF Technologies 

$1.99
0
+$0.03+1.53% Today

Statistics

Day High
1.99
Day Low
1.98
52W High
-
52W Low
-
Volume
144
Avg. Volume
-
Mkt Cap
4.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1OctExpected
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-29.18MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRFX.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pacira BioSciences
PCRX
Mkt Cap997.06M
Pacira Biosciences specializes in non-opioid pain management, directly competing with PainReform's post-operative pain solutions.
Heron Therapeutics
HRTX
Mkt Cap212.64M
Heron Therapeutics focuses on improving the patient experience by developing best-in-class treatments for acute and chronic pain, similar to PainReform's objectives.
Trevena
TRVN
Mkt Cap10,365
Trevena, Inc. develops novel medicines for patients affected by pain, offering alternatives that could compete with PainReform's products.
Evolus
EOLS
Mkt Cap417.87M
Evolus operates in the medical aesthetics market but its focus on non-surgical treatments could indirectly compete with PainReform's pain management solutions.
CorMedix
CRMD
Mkt Cap872.03M
CorMedix Inc. focuses on preventing and treating infections and inflammatory diseases, which could overlap with PainReform's target market in post-operative care.
Nektar Therapeutics
NKTR
Mkt Cap1.23B
Nektar Therapeutics works on drug development that includes pain management solutions, potentially competing with PainReform's portfolio.
Collegium Pharmaceutical
COLL
Mkt Cap1.13B
Collegium Pharmaceutical is dedicated to developing and commercializing new medications for pain management, directly competing with PainReform.

About

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
Show more...
CEO
ISIN
IL0011651580

Listings

BOATS
BOATS
PRFX.BOATS
XNAS
US
PRFX

0 Comments

Share your thoughts

FAQ

What is PRF Technologies stock price today?▼
The current price of PRFX.BOATS is $1.99 USD — it has increased by +1.53% in the past 24 hours. Watch PRF Technologies stock price performance more closely on the chart.
What is PRF Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange PRF Technologies stocks are traded under the ticker PRFX.BOATS.
What is PRF Technologies market cap?▼
Today PRF Technologies has the market capitalization of 4.01M
What is PRF Technologies revenue for the last year?▼
PRF Technologies revenue for the last year amounts to 0 USD.
What is PRF Technologies net income for the last year?▼
PRFX.BOATS net income for the last year is -29.18M USD.
When did PRF Technologies complete a stock split?▼
The last stock split for PRF Technologies was on February 06, 2026 with a ratio of 1:5.